Uncovering the Uncommon: Efficacy of Afatinib in
Uncommon and Compound Mutations
Speaker: Dr Cheah Soon Keat
Document ID: PC-MY-102059
Watch Dr Cheah Soon Keat as he discusses on the latest
treatment strategy of treating uncommon EGFR mutation positive NSCLC patients based on evidence and
clinical experience.
Speaker
Dr Cheah Soon Keat
Consultant Clinical Oncologist
Island Hospital Penang, Malaysia
Running the Marathon: Updated Evidence on Sequential EGFR TKI Approach in NSCLC (Presentation)
Speaker: Dr. Maximilian Hochmair
PeRsonalized apprOach in Lung adenocarciNoma with EGFR-TKI therapy (PROLONG)
Speaker: Assoc Prof Dr Ho Gwo-Fuang